Sana Biotechnology
SANA
SANA
136 hedge funds and large institutions have $493M invested in Sana Biotechnology in 2023 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 42 increasing their positions, 39 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
8% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 39
5.72% less ownership
Funds ownership: 70.47% → 64.75% (-5.7%)
39% less capital invested
Capital invested by funds: $804M → $493M (-$311M)
Holders
136
Holding in Top 10
4
Calls
$204K
Puts
$165K
Top Buyers
| 1 | +$7.36M | |
| 2 | +$4.76M | |
| 3 | +$3.29M | |
| 4 |
SOMRS
State of Michigan Retirement System
Lansing,
Michigan
|
+$2.66M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$2.09M |
Top Sellers
| 1 | -$32.1M | |
| 2 | -$14.5M | |
| 3 | -$2.88M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$2.45M |
| 5 |
AG
Artal Group
Luxembourg
|
-$2.38M |